Mission Bay Capital
VC
INVESTOR TYPE
Active
STATUS
3
PROFESSIONALS
57
INVESTMENTS
32
PORTFOLIO
10
EXITS
Description
Mission Bay Capital is a venture capital firm focused on making startup and early-stage investments in bio-science firms emerging from the California Institute for Quantitative Biosciences and the University of California. The firm helps entrepreneurial scientist create successful firms that take on problems like chronic diseases and global environmental challenges. It was founded in 2009 and is based in San Francisco, California.
Website
Investor Status
Actively Seeking New Investments
Year Founded
2009
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Primary Office
- 953 Indiana Street
- San Francisco, CA 94107
- United States
+1 (415) 000-0000
Mission Bay Capital Investments (57)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| LogicInk | 06-Nov-2019 | Early Stage VC | 000 | Electronics (B2C) | Generating Revenue | |
| 000000000 | 07-Aug-2019 | 00000 00000 | 0000 | Drug Delivery | Clinical Trials - General | |
| 000000 00000000000 | 21-Mar-2019 | 0000 00000 | 000 | Drug Delivery | Startup | 0000000 00000000 00.0 |
| 00000000 0000000 | 15-Jan-2019 | 00000 00000 | 00.00 | Other Healthcare Services | Generating Revenue | 0000000 00000000 00.0 |
| 0000000 0000000000 | 23-Aug-2018 | 00000 00000 | 00.000 | Biotechnology | Generating Revenue | |
| 0000000 | 25-Jul-2018 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue/Not Profitable | |
| 00000000000 000000 | 29-Mar-2018 | 00000 00000 | 00000 | Biotechnology | Generating Revenue | |
| 0000 0000 | 29-Mar-2018 | 0000 00000 | 00.00 | Food Products | Generating Revenue | |
| Pionyr Immunotherapeutics | 28-Mar-2018 | Early Stage VC | 0000 | Biotechnology | Startup | |
| ViewPoint Therapeutics | 05-Mar-2018 | Early Stage VC | 0000 | Biotechnology | Startup |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Mission Bay Capital’s full profile, request a free trial.
Mission Bay Capital Exits (10)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Atreca | 20-Jun-2019 | IPO | 00000 | Completed |
|
| 0000 0000000000 | 01-Jun-2019 | 000 00 00000000 | Completed |
|
|
| 0000000 | 07-Feb-2019 | 000 | 00000 | Completed |
|
| 000000000 00000000 | 14-Sep-2018 | 000 | 00000 | Completed |
|
| 0000 000000 0000 | 01-Dec-2017 | 000000000000000000 | 00000 | Completed |
|
| 0000 00000 0000000 | 28-Jun-2017 | 000000000000000000 | 00000 | Completed |
|
| 00000000 000000000 | 14-Mar-2016 | 000000000000000000 | 0000 | Completed |
|
| 000000000 00000000 | 02-Oct-2014 | 000 | 0000 | Completed |
|
| Redwood Bioscience | 02-Oct-2014 | Merger/Acquisition | Completed | ||
| iPierian | 29-Apr-2014 | Merger/Acquisition | 00000 | Completed |
Mission Bay Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is reserved for PitchBook Platform accredited users. To explore Mission Bay Capital‘s full profile, request access.
Request full access to PitchBookMission Bay Capital Team (18)
3 Former Team Members
You’re viewing 5 of 18 team members. Get the full list »Mission Bay Capital Co-Investors (123)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| BioInnovation Capital | 5 | 0 | |
| California Institute for Quantitative Biosciences | 0 | 0 | |
| Osage University Partners | 0 | 0 | 0 |
| Canaan Partners | 0 | 0 | |
| Kleiner Perkins | 0 | 0 | 0 |